Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

335 ta ish

Ish: CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

  1. The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway

    Michael R. Lieber

    Sharh maqola20102 iqtibos
    ABI

  2. A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging

    Marvin E. Tanenbaum, Luke A. Gilbert, Lei S. Qi +2

    Maqola20142 iqtibos
    ABI

  3. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy

    Chengzu Long, Leonela Amoasii, Alex A. Mireault +7

    Maqola20152 iqtibos
    ABI

  4. In vivo gene editing in dystrophic mouse muscle and muscle stem cells

    Mohammadsharif Tabebordbar, Kexian Zhu, Jason Cheng +12

    Maqola20152 iqtibos
    ABI

  5. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA

    Chris D. Richardson, Graham J. Ray, Mark A. DeWitt +2

    Maqola20162 iqtibos
    ABI

  6. DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology

    Ricardo Taipa, Conceição Pereira, Inês Reis +4

    Maqola20162 iqtibos
    ABI

  7. Diversity, classification and evolution of CRISPR-Cas systems

    Eugene V. Koonin, Kira S. Makarova, Feng Zhang

    Sharh maqola20172 iqtibos
    ABI

  8. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications

    Chang Liu, Li Zhang, Hao Liu +1

    Sharh maqola20172 iqtibos
    ABI

  9. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage

    Nicole M. Gaudelli, Alexis C. Komor, Holly A. Rees +4

    Maqola20172 iqtibos
    ABI

  10. Crossing the blood-brain barrier with nanoparticles

    Yiqun Zhou, Zhili Peng, Elif S. Seven +1

    Sharh maqola20172 iqtibos
    ABI

  11. The CRISPR tool kit for genome editing and beyond

    Mazhar Adli

    Sharh maqola20182 iqtibos
    ABI

  12. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

    Mike A. Nalls, Cornelis Blauwendraat, Costanza L. Vallerga +90

    Sharh maqola20192 iqtibos
    ABI

  13. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

    Hongyi Li, Yang Yang, Weiqi Hong +3

    Sharh maqola20202 iqtibos
    ABI

  14. Recent Advances in CRISPR/Cas9 Delivery Strategies

    Bon Ham Yip

    Sharh maqola20202 iqtibos
    ABI

  15. Nobel Prize 2020 in Chemistry honors CRISPR: a tool for rewriting the code of life

    Lukas Westermann, Björn Neubauer, Michael Köttgen

    Tahririyat maqolasi20202 iqtibos
    ABI

  16. Exosome-mediated delivery of gene vectors for gene therapy

    Li Duan, Limei Xu, Xiao Xu +5

    Sharh maqola20202 iqtibos
    ABI

  17. Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

    Bwalya A. Witika, Madan Poka, Patrick H. Demana +4

    Sharh maqola20222 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI